Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Severin Schwan
Biotech
Roche, Biogen temper Alzheimer's expectations in Q2 calls
Executives from two of the three major players in Alzheimer's disease—Roche and Biogen—seem to be tempering expectations for success.
Annalee Armstrong
Jul 22, 2022 9:07am
COVID-19 antibody tests 'a disaster,' says Roche CEO
Apr 22, 2020 10:45am
Roche CEO says COVID-19 diagnostics still short of demand: CNBC
Mar 23, 2020 3:45pm
